Testing a new imaging system for nuclear medicine scans
This study tests a new camera (StarGuide NextGen SPECT/CT) that takes 3D pictures of your body after you receive a radioactive tracer. It may help doctors see disease more clearly during your scheduled nuclear medicine test or treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to have a nuclear medicine imaging test or treatment that uses a radioactive drug.
- You can lie flat on your back on a scanning bed for the procedure.
- You are not pregnant.
- You are able to give your own permission to be in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether having an extra SPECT/CT scan provides clearer images. If you already need a SPECT/CT scan, you may be able to join, and the extra scan might help improve imaging technology.
This study tests a new way of taking pictures of tumors (metastases) using an upgraded gamma camera. The goal is to see if this new method produces clearer images, which could help doctors find and treat cancer better. Participation is only for people who are already having a bone scan or a scan after certain types of radiation therapy.
This study is testing a new type of MRI scanner that uses special techniques to create clearer images. You may be able to help by undergoing a scan and providing feedback.
This study tests a new type of CT scanner called Spectral CT Verida, which takes detailed images of the body. It aims to see how well the scanner works and whether it is safe for people to use.
This trial studies a new X-ray platform that may give clearer images during body scans. It will see how well it works in real life and may lead to better imaging for patients.
This study tests a special camera that may help doctors aim radiation more precisely at bone tumors in people with prostate cancer. It could improve the accuracy of treatment while reducing harm to healthy tissue.
Hear when a new Nuclear Medicine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.